History of Indwelling Catheters - Bard

For 106 years C. R. Bard, Inc. has maintained its dedication to creating innovative products and services for health-care providers and patients worldwide.  Through its strong traditions of quality, integrity, service and innovation, Bard serves as a leading developer, manufacturer and marketer of quality of life enhancing medical technologies to thousands of health-care professionals and facilities all focused towards improving patient outcomes.

 

In 1907 when company founder Charles Russell Bard began researching treatments for urinary discomfort, little did he realize that his vision and work would revolutionize the medical marketplace, leading to major advancements in patient care. his extensive studies and his professional relationship with Frederick E. B. Foley, led to major innovations, including the development of the first balloon catheter, a modern device that clinicians immediately embraced. C. R. Bard, Inc.'s formal incorporation in 1923 served as the first step toward the creation of a global company that has excelled for more than a century and improved the lives of millions.

The UroToday Urologic Catheter Center is another contribution from Bard in 2013 to the health-care community and the patients we serve.  Bard medical has grown from the vision and work of a single individual to a global company with over 9000 employees and business operations in 90 countries. We honor the past achievements and contributions of C. R. Bard who have continually improved upon the indwelling catheter, providing the health-care community with products that deliver superior medical care in 2013. Bard's innovations are backed up by a superior commitment to quality and strong values.

The Urologic Catheter Center is sponsored by Bard Medical and is a reflection of the values of Quality, Integrity, Service and Innovation of the products and their people.  UroToday is grateful to Bard Medical for their visionary support of this unique educational initiative which brings to clinicians and health-care decision makers and patients the resources they need to make evidence-based decisions about product selection and tools that support preventing catheter-associated urinary tract infections.

The C. R. Bard history is adapted from Poser of the Past, Force of the Future BARD Jeffrey L. Rodengen.

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe